Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Company Description

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China.

Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields.

The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, and children's respiratory system chinese patent medicines; and Xiaojin pills, Tian Ranshexiang Xiaojin pills, Xiaokechuan capsules, Jiuwei Qianghuo granules, Bear Bile powder, and Wenweishu tablets to treat glandular hyperplasia, inflammatory diseases, bone trauma and soft tissue injury, and other related diseases.

In addition, the company offers bacillus cereus live bacteria capsules, bacillus cereus live bacteria tablets are therapeutic live bacteria microecological preparations to treat enteritis, diarrhea, infantile diarrhea, and intestinal dysfunction.

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd. was founded in 1990 and is based in Tonghua City, China.

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

Country	China
Founded	1990
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	1,696
CEO	Hongjun Zhan

Contact Details

Address: No. 999, Jinma Road Tonghua City, 134003 China
Phone	86 43 5324 6712
Website	thjm.cn

Stock Details

Ticker Symbol	000766
Exchange	Shenzhen Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE000000735
SIC Code	2834

Key Executives

Name	Position
Hongjun Zhan Ph.D.	General Manager
Jun Yu	Deputy GM and Chief Financial Officer
Yu Jing	Deputy GM and Non-Independent Director
Weilin Jia	Secretary and Deputy GM